Xcout Intel
Myricx Bio competitors & alternatives
The 12 closest competitors and alternatives to Myricx Bio among biotechnology companies — ranked by similarity to what Myricx Bio actually does, not by market-cap band.
Subscribe to see Myricx Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Myricx Bio
Myricx Bio is a UK biotech company headquartered in London. It specializes in the discovery and development of a novel class of selective cytotoxic payloads for Antibody-Drug Conjugates (ADCs).
Myricx Bio at a glance
Myricx Bio is a biotechnology company headquartered in United Kingdom. It has raised at least $115M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $114M in July 2024. Xcout tracks 6 named people at Myricx Bio, including Mohit Rawat (Chief Executive Officer).
Myricx Bio leadership
- Mohit RawatChief Executive Officer
- Chris MartinChairman and Non Executive Director
- Jayson PunwaniNon Executive Director
- Jonathan TobinNon Executive Director
- Maina BhamanNon Executive Director
- Michael BauerNon Executive Director
Myricx Bio funding rounds
At least $115M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $114M | 1 named | |
| — | $5.8M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Myricx Bio news
Top 12 Myricx Bio competitors
Ranked by semantic similarity — how close each company is to Myricx Bio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Adcytherix is a clinical-stage biopharmaceutical company that develops next-generation antibody-drug conjugates (ADCs) for oncology. The company combines clinically validated targets with innovative payloads derived from approved cancer drugs to treat resistant cancers and address unmet medical needs.
Similar biotechnology company
Pheon Therapeutics is a biotechnology research company headquartered in London, England, that specializes in developing next-generation antibody-drug conjugates for hard-to-treat cancers.
Similar biotechnology company
Mythic Therapeutics, Inc. is a biotechnology research company headquartered in Waltham, Massachusetts. The company is dedicated to developing a proprietary platform to enhance the effectiveness of antibody-drug conjugates and other antibody-based therapeutics.
Biotech
AbTx (Antibody for Therapy) is a preclinical-stage biotechnology company headquartered in Dijon, France. The firm designs personalized medicine biotherapies in oncology based on antibody-drug conjugates (ADCs) to treat incurable cancers.
Similar biotechnology company
NBE-Therapeutics is a biotechnology company founded in 2012 and headquartered in Basel, Switzerland, focused on developing antibody-drug conjugates for oncology treatments.
Biotech
CrossBridge Bio, Inc. is a medical technology and biopharmaceutical company pioneering an approach to deliver the next generation of stable antibody-drug conjugates (ADCs).
Similar biotechnology company
Tubulis is a biotechnology organization headquartered in Munich that generates uniquely matched antibody-drug conjugates with superior biophysical properties.
Similar biotechnology company
Adcendo ApS is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with supplementary operations in Boston, Massachusetts. The company specializes in the development of innovative antibody-drug conjugates (ADCs) targeting various oncology indications. Its pipeline focuses on delivering best-in-class clinical treatments for patients with high unmet medical needs.
Life Sciences
MitoRx Therapeutics is a platform biotechnology company headquartered in Oxford, England, developing novel mitochondrial-targeted therapeutics for life sciences.
Similar biotechnology company
LigaChem Biosciences is a clinical-stage biopharmaceutical company headquartered in Daejeon, South Korea. The company specializes in the discovery and development of novel therapeutics utilizing proprietary technology platforms such as antibody-drug conjugates. With decades of dedicated drug development experience, it drives global healthcare innovation through open collaboration.
Similar biotechnology company
Cybrexa Therapeutics is a clinical-stage oncology biotechnology company that develops tumor-targeting peptide-drug conjugates (PDCs) for cancer patients. Its proprietary alphalex technology uses a pH-driven approach for antigen-independent, intracellular delivery of anti-cancer agents directly to tumors and metastases.
Life Sciences
Curve Therapeutics is a private biotechnology company headquartered in Southampton, United Kingdom, pioneering a revolutionary proprietary microcycle drug discovery platform to address challenging intracellular targets.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Myricx Bio and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Myricx Bioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →